ImportRefusal LogoImportRefusal

Abbott Laboratories de Mexico, S.A. de C.V.

⚠️ High Risk

FEI: 3007262154 • Ciudad De Mexico, Ciudad de Mexico • MEXICO

FEI

FEI Number

3007262154

📍

Location

Ciudad De Mexico, Ciudad de Mexico

🇲🇽

Country

MEXICO
🏢

Address

Avenida Calzada De Tlalpan 3092, Col. Exhacienda Coapa, Coyoacan, Ciudad De Mexico, Ciudad de Mexico, Mexico

High Risk

FDA Import Risk Assessment

69.0
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

55
Total Refusals
9
Unique Violations
11/26/2025
Latest Refusal
8/20/2002
Earliest Refusal

Score Breakdown

Violation Severity
69.3×40%
Refusal Volume
64.8×30%
Recency
97.3×20%
Frequency
23.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7526×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1118×

UNSAFE COL

The article appears to be, or to bear or contain a color additive which is unsafe within the meaning of Section 721(a).

32410×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

2608×

FALSE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.

2747×

COLOR LBLG

The article appears to contain an artificial coloring and it fails to bear labeling stating that fact.

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

2182×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

38651×

COLORLABEL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use.

Refusal History

DateProductViolationsDivision
11/26/2025
58CAY99ANTIMIGRAINE, NEC
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/28/2024
61FDA56CLARITHROMYCIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/27/2024
54YGY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/7/2023
61MDY41VALPROIC ACID (ANTI-CONVULSANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/28/2022
62KCA99ANTI-PERISTALTIC N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/19/2020
63ECA28PROPAFENONE HYDROCHLORIDE (CARDIAC DEPRESSANT (ANTI-ARRHYTHMIC))
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/3/2019
63ECY28PROPAFENONE HYDROCHLORIDE (CARDIAC DEPRESSANT (ANTI-ARRHYTHMIC))
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/16/2018
66SDY03BETAHISTINE HCL (VASODILATOR)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/21/2018
64LCK19DEXAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/30/2017
66JDY01LEVOTHYROXINE SODIUM (THYROID HORMONE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/12/2017
64ECC02PANCREATIN (ENZYME)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/4/2017
66VCA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/10/2017
61JDH09FENOFIBRATE (ANTI-CHOLESTEREMIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/6/2016
41GHT03ORAL REHYDRATION PRODUCTS
75UNAPPROVED
Southwest Import District Office (SWI-DO)
8/9/2016
66SCC03BETAHISTINE HCL (VASODILATOR)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/30/2016
62OCA28ENALAPRIL MALEATE (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/30/2016
65QCA44MEBEVERINE HCL (RELAXANT)
75UNAPPROVED
New Orleans District Office (NOL-DO)
2/23/2016
41GHT03ORAL REHYDRATION PRODUCTS
260FALSE
324NO ENGLISH
Southwest Import District Office (SWI-DO)
2/23/2016
41GHT03ORAL REHYDRATION PRODUCTS
260FALSE
324NO ENGLISH
Southwest Import District Office (SWI-DO)
2/23/2016
41GHT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
260FALSE
324NO ENGLISH
3865COLORLABEL
Southwest Import District Office (SWI-DO)
2/23/2016
41GHT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
260FALSE
274COLOR LBLG
324NO ENGLISH
Southwest Import District Office (SWI-DO)
4/9/2015
41GGY03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
274COLOR LBLG
Southwest Import District Office (SWI-DO)
4/9/2015
41GGY03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
274COLOR LBLG
Southwest Import District Office (SWI-DO)
4/30/2012
62VAF37RITONAVIR (ANTI-VIRAL)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/30/2012
62OCB13VERAPAMIL HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
New Orleans District Office (NOL-DO)
11/1/2010
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
Southwest Import District Office (SWI-DO)
11/1/2010
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
Southwest Import District Office (SWI-DO)
11/1/2010
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
Southwest Import District Office (SWI-DO)
6/23/2009
41GGT03ORAL REHYDRATION PRODUCTS
218LIST INGRE
324NO ENGLISH
Southwest Import District Office (SWI-DO)
6/23/2009
41GGT03ORAL REHYDRATION PRODUCTS
218LIST INGRE
324NO ENGLISH
Southwest Import District Office (SWI-DO)
6/23/2009
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
274COLOR LBLG
Southwest Import District Office (SWI-DO)
5/28/2009
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
274COLOR LBLG
324NO ENGLISH
Southwest Import District Office (SWI-DO)
5/15/2009
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
Southwest Import District Office (SWI-DO)
4/21/2009
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
Southwest Import District Office (SWI-DO)
4/21/2009
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
Southwest Import District Office (SWI-DO)
4/21/2009
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
Southwest Import District Office (SWI-DO)
4/21/2009
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
Southwest Import District Office (SWI-DO)
2/10/2009
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
Southwest Import District Office (SWI-DO)
10/2/2008
63BAL99BRONCHODILATOR N.E.C.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
8/20/2008
41GGT03ORAL REHYDRATION PRODUCTS
274COLOR LBLG
Southwest Import District Office (SWI-DO)
8/20/2008
41GGT03ORAL REHYDRATION PRODUCTS
274COLOR LBLG
Southwest Import District Office (SWI-DO)
2/11/2008
56ICL10ERYTHROMYCIN (MACROLIDES)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/10/2007
66SCA48ISOSORBIDE MONONITRATE (VASODILATOR)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
6/26/2007
41GGT03ORAL REHYDRATION PRODUCTS
260FALSE
Southwest Import District Office (SWI-DO)
6/26/2007
41GGT03ORAL REHYDRATION PRODUCTS
260FALSE
Southwest Import District Office (SWI-DO)
6/26/2007
41GGT03ORAL REHYDRATION PRODUCTS
260FALSE
Southwest Import District Office (SWI-DO)
6/26/2007
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
260FALSE
Southwest Import District Office (SWI-DO)
4/10/2007
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
Southwest Import District Office (SWI-DO)
11/8/2006
41GGT03ORAL REHYDRATION PRODUCTS
324NO ENGLISH
Southwest Import District Office (SWI-DO)
10/16/2006
41GGT03ORAL REHYDRATION PRODUCTS
324NO ENGLISH
Southwest Import District Office (SWI-DO)
8/24/2006
41GGT03ORAL REHYDRATION PRODUCTS
11UNSAFE COL
324NO ENGLISH
Southwest Import District Office (SWI-DO)
2/15/2005
60RCB19SIBUTRAMINE HCL MONOHYDRATE (ANOREXIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/10/2003
54BYL12SODIUM (MINERAL)
16DIRECTIONS
75UNAPPROVED
Southwest Import District Office (SWI-DO)
8/20/2002
66YBL99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Southwest Import District Office (SWI-DO)
8/20/2002
66YBL99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Southwest Import District Office (SWI-DO)

Frequently Asked Questions

What is Abbott Laboratories de Mexico, S.A. de C.V.'s FDA import refusal history?

Abbott Laboratories de Mexico, S.A. de C.V. (FEI: 3007262154) has 55 FDA import refusal record(s) in our database, spanning from 8/20/2002 to 11/26/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Abbott Laboratories de Mexico, S.A. de C.V.'s FEI number is 3007262154.

What types of violations has Abbott Laboratories de Mexico, S.A. de C.V. received?

Abbott Laboratories de Mexico, S.A. de C.V. has been cited for 9 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Abbott Laboratories de Mexico, S.A. de C.V. come from?

All FDA import refusal data for Abbott Laboratories de Mexico, S.A. de C.V. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.